{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:41:12Z","timestamp":1786545672764,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/ajg.2012.419","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T10:41:04Z","timestamp":1357641664000},"page":"249-255","source":"Crossref","is-referenced-by-count":18,"title":["A Random Urine Test Can Identify Patients at Risk of Mesalamine Non-Adherence: A Prospective Study"],"prefix":"10.14309","volume":"108","author":[{"given":"Anne E","family":"Gifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders H","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Lahiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210210","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1572-0241.2001.04683.x","article-title":"Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.","volume":"96","author":"Kane","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R2-20-20210210","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s10620-011-1877-6","article-title":"Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.","volume":"56","author":"Kane","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R3-20-20210210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(02)01383-9","article-title":"Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.","volume":"114","author":"Kane","year":"2003","journal-title":"Am J Med"},{"key":"R4-20-20210210","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s10620-007-9968-0","article-title":"Medication non-adherence is associated with increased medical health care costs.","volume":"53","author":"Kane","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R5-20-20210210","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ibd.20189","article-title":"Non-adherence in inflammatory bowel disease: results of factor analysis.","volume":"13","author":"Cerveny","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R6-20-20210210","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1572-0241.2007.01212.x","article-title":"Predictors of medication adherence in inflammatory bowel disease.","volume":"102","author":"Ediger","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R7-20-20210210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2036.2006.02809.x","article-title":"Systematic review: adherence issues in the treatment of ulcerative colitis.","volume":"23","author":"Kane","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-20-20210210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ibd.21310","article-title":"Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.","volume":"17","author":"Trindade","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R9-20-20210210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2288-11-149","article-title":"Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.","volume":"11","author":"Garfield","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"R10-20-20210210","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.","volume":"28","author":"Shi","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"R11-20-20210210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ajg.2011.317","article-title":"Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.","volume":"107","author":"Kane","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R12-20-20210210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/MCG.0b013e3182192207","article-title":"Current practice and perception of screening for medication adherence in inflammatory bowel disease.","volume":"45","author":"Trindade","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R13-20-20210210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pec.2009.12.010","article-title":"Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study.","volume":"81","author":"Cook","year":"2010","journal-title":"Patient Educ Couns"},{"key":"R14-20-20210210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2362.2007.01809.x","article-title":"A clinical trial on absorption and N-acetylation of oral and rectal mesalazine.","volume":"37","author":"Dilger","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R15-20-20210210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gut.28.2.196","article-title":"Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract.","volume":"28","author":"Myers","year":"1987","journal-title":"Gut"},{"key":"R16-20-20210210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2036.2003.01408.x","article-title":"SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.","volume":"17","author":"Sandborn","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-20-20210210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chroma.2006.01.058","article-title":"High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma.","volume":"1119","author":"Nobilis","year":"2006","journal-title":"J Chromatogr A"},{"key":"R18-20-20210210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/clinchem\/21.8.1167","article-title":"Improved colorimetric determination of salicylic acid and its metabolites in urine.","volume":"21","author":"Farid","year":"1975","journal-title":"Clin Chem"},{"key":"R19-20-20210210","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1365-2036.2002.01375.x","article-title":"Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds.","volume":"16","author":"Shaw","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-20-20210210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting.","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R21-20-20210210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index.","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"R22-20-20210210","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R23-20-20210210","first-page":"59","article-title":"New medication adherence scale versus pharmacy fill rates in seniors with hypertension.","volume":"15","author":"Krousel-Wood","year":"2009","journal-title":"Am J Manag Care"},{"key":"R24-20-20210210","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s10620-006-9444-2","article-title":"Medication-taking behavior in a cohort of patients with inflammatory bowel disease.","volume":"51","author":"Bernal","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R25-20-20210210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.2008.03865.x","article-title":"Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.","volume":"29","author":"Higgins","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-20-20210210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"key":"R27-20-20210210","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2036.2009.04152.x","article-title":"An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements.","volume":"30","author":"Moshkovska","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20-20210210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1310\/hct0904-238","article-title":"White coat compliance limits the reliability of therapeutic drug monitoring in HIV-1-infected patients.","volume":"9","author":"Podsadecki","year":"2008","journal-title":"HIV Clin Trials"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2012419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012419","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201302000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:03Z","timestamp":1786542303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201302000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2012.419","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}